Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dan L. Longo is active.

Publication


Featured researches published by Dan L. Longo.


Archive | 1986

Primary Solid Tumors of the Heart

Walter J. Urba; Dan L. Longo

Primary cardiac tumors are extremely rare, occurring in 0.0017–0.28% of autopsy specimens.1–4 These lesions were predominantly pathologic curiosities demonstrated only post mortem until the initial clinical diagnosis by Barnes et al.5 in 1934 of a primary sarcoma of the heart. The correct antemortem diagnosis of an intracardiac tumor remained largely academic until the advent of modern cardiopulmonary bypass surgical techniques. Because of surgical advances, cardiac tumors now represent a potentially curable form of heart disease. Accurate diagnosis is complicated by other cardiac and noncardiac diseases.6 The clinical manifestations of cardiac tumors are protean and relate primarily to their location within the heart.7


Archive | 2001

Cancer chemotherapy and biotherapy : principles and practice

Bruce Chabner; Dan L. Longo


Archive | 1997

Methods of identifying patients having an altered immune status

Augusto C. Ochoa; Howard A. Young; Dan L. Longo; Paritosh Ghosh; Richard J. Robb; Mary E. Neville


Archive | 1993

Evaluation and treatment of patients with progressive immunosuppression

Augusto C. Ochoa; Dan L. Longo; Paritosh Ghosh; Howard A. Young


Archive | 1992

Short-term anti-CD3 stimulation of lymphocytes to increase their in vivo acitivity

Augusto C. Ochoa; Cynthia M. Loeffler; Walter Urba; Dan L. Longo


Archive | 1992

Evaluation and treatment of patients with progessive immunosuppression

Augusto C. Ochoa; Hiromoto Mizoguchi; John J. O'Shea; Dan L. Longo; Cynthia M. Loeffler


Archive | 1994

Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations

Augusto C. Ochoa; Mark L. Saxton; Dan L. Longo


Archive | 1995

METHOD OF ENHANCING THE IMMUNOTHERAPEUTIC ACTIVITY OF IMMUNE CELLS BY DEPLETION/POSITIVE SELECTION

Augusto C. Ochoa; Mark L. Saxton; Dan L. Longo


Archive | 2010

Major Breakpoint Region

Edward H. Lipford; John J. Wright; Walter J. Urba; Jacqueline Whang-Peng; Ilan R. Kirsch; Mark Raffeld; Jeffrey Cossman; Dan L. Longo; Ajay Bakhshi; Stanley J. Korsmeyer


Archive | 2010

pharmacodynamic approach with high efficacy Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a

D. Cheson; Dan L. Longo; Nancy Lee Harris; Elaine S. Jaffe; Bruce A. Chabner; Robert E. Wittes; Frank Balis Bruce; Seth M. Steinberg; Richard F. Little; John E. Janik; Martin Gutierrez; Mark Raffeld; Louis M. Staudt; Wyndham H. Wilson; Michael L. Grossbard; Stefania Pittaluga; Diane E. Cole; Deborah Pearson

Collaboration


Dive into the Dan L. Longo's collaboration.

Top Co-Authors

Avatar

Paritosh Ghosh

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Howard A. Young

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

Augusto C. Ochoa

LSU Health Sciences Center New Orleans

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John J. O'Shea

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Walter J. Urba

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark Raffeld

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge